rs751302717

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6_ModerateBS1BS2

The NM_004484.4(GPC3):​c.392A>G​(p.Lys131Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000365 in 1,206,375 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 14 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K131E) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.000038 ( 0 hom. 14 hem. )

Consequence

GPC3
NM_004484.4 missense

Scores

16

Clinical Significance

Benign criteria provided, single submitter U:2B:1

Conservation

PhyloP100: 1.03

Publications

2 publications found
Variant links:
Genes affected
GPC3 (HGNC:4451): (glypican 3) Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
GPC3 Gene-Disease associations (from GenCC):
  • Simpson-Golabi-Behmel syndrome
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Simpson-Golabi-Behmel syndrome type 1
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.13945371).
BP6
Variant X-133754122-T-C is Benign according to our data. Variant chrX-133754122-T-C is described in ClinVar as Benign. ClinVar VariationId is 239943.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.0000383 (42/1096572) while in subpopulation NFE AF = 0.0000488 (41/840756). AF 95% confidence interval is 0.0000363. There are 0 homozygotes in GnomAdExome4. There are 14 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Hemizygotes in GnomAdExome4 at 14 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GPC3NM_004484.4 linkc.392A>G p.Lys131Arg missense_variant Exon 3 of 8 ENST00000370818.8 NP_004475.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GPC3ENST00000370818.8 linkc.392A>G p.Lys131Arg missense_variant Exon 3 of 8 1 NM_004484.4 ENSP00000359854.3

Frequencies

GnomAD3 genomes
AF:
0.0000182
AC:
2
AN:
109803
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000380
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000220
AC:
4
AN:
181962
AF XY:
0.0000149
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000372
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000383
AC:
42
AN:
1096572
Hom.:
0
Cov.:
32
AF XY:
0.0000387
AC XY:
14
AN XY:
361966
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26363
American (AMR)
AF:
0.00
AC:
0
AN:
35184
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19373
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30199
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54065
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40462
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4127
European-Non Finnish (NFE)
AF:
0.0000488
AC:
41
AN:
840756
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46043
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000182
AC:
2
AN:
109803
Hom.:
0
Cov.:
22
AF XY:
0.00
AC XY:
0
AN XY:
32073
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30069
American (AMR)
AF:
0.00
AC:
0
AN:
10243
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2629
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3534
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2492
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5814
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
233
European-Non Finnish (NFE)
AF:
0.0000380
AC:
2
AN:
52644
Other (OTH)
AF:
0.00
AC:
0
AN:
1462
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000142
Hom.:
1
Bravo
AF:
0.000110
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Benign
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:2
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

Wilms tumor 1 Benign:1
Jul 21, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.80
CADD
Benign
17
DANN
Benign
0.94
DEOGEN2
Benign
0.26
T;.;.
FATHMM_MKL
Benign
0.58
D
LIST_S2
Benign
0.82
T;T;T
M_CAP
Benign
0.0041
T
MetaRNN
Benign
0.14
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.20
N;N;.
PhyloP100
1.0
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-0.10
N;N;.
REVEL
Benign
0.081
Sift
Benign
0.76
T;T;.
Sift4G
Benign
0.84
T;T;T
Vest4
0.11
ClinPred
0.038
T
GERP RS
3.9
PromoterAI
-0.0079
Neutral
Varity_R
0.11
gMVP
0.32
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs751302717; hg19: chrX-132888149; API